Detalhe da pesquisa
1.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021929
2.
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis.
Ann Hematol
; 102(6): 1443-1458, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093241
3.
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
Am J Hematol
; 97(7): 877-884, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389534
4.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 22(3): e105-e118, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662288
5.
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Cancer
; 127(22): 4233-4239, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374445
6.
Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
Cancer
; 127(11): 1816-1826, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735504
7.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Cancer
; 127(1): 82-92, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966625
8.
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Br J Haematol
; 194(3): 496-507, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724461
9.
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 96(2): 226-233, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125764
10.
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
Biol Blood Marrow Transplant
; 26(4): 798-804, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756536
11.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
12.
The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.
Nephrol Dial Transplant
; 34(9): 1440-1452, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169860
13.
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(2): 231-244, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938772
14.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
Br J Haematol
; 180(6): 831-839, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315478
15.
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Lancet Oncol
; 18(4): e206-e217, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368259
16.
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.
Biol Blood Marrow Transplant
; 23(1): 60-66, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789362
17.
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Cancer
; 123(16): 3141-3149, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472539
18.
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
Br J Haematol
; 176(3): 440-447, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859001
19.
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series.
Hematol Oncol
; 35(2): 246-251, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27018162
20.
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.
Ann Hematol
; 96(10): 1693-1698, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766002